Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis

GM1 gangliosidosis is an autosomal recessive neurodegenerative disorder caused by the deficiency of lysosomal β-galactosidase (β-gal) and resulting in accumulation of GM1 ganglioside. The disease spectrum ranges from infantile to late onset and is uniformly fatal, with no effective therapy currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Latour, Yvonne L., Yoon, Robin, Thomas, Sarah E., Grant, Christina, Li, Cuiling, Sena-Esteves, Miguel, Allende, Maria L., Proia, Richard L., Tifft, Cynthia J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744524/
https://www.ncbi.nlm.nih.gov/pubmed/31534909
http://dx.doi.org/10.1016/j.ymgmr.2019.100513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744524/
https://www.ncbi.nlm.nih.gov/pubmed/31534909
http://dx.doi.org/10.1016/j.ymgmr.2019.100513

Ejemplares similares